With reference to the captioned subject matter, pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 , we hereby submit the certificate received from the M/s R&D Infotech Private ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has filed a routine compliance certificate with BSE, Ahmedabad Stock Exchange, and Calcutta Stock Exchange under SEBI's Regulation 74(5). The certificate, issued by the company's Registrar and Transfer Agent M/s R&D Infotech Private Limited, confirms that all securities received from depository participants for dematerialisation during Q1 FY26 (quarter ended June 30, 2025) were properly processed and confirmed to the depositories. It also confirms that physical certificates received for demat have been mutilated, cancelled, and the depository's name substituted as the registered owner in the company's records within the 15-day SEBI-mandated timeline. This is a standard quarterly procedural submission with no financial figures or business updates.
This is a routine regulatory compliance filing with no material impact on shareholders, operations, or stock price. It simply fulfils an ongoing SEBI requirement to confirm proper handling of dematerialisation requests.